baber/WOPTO huggingface dataset:
Patent NZ-564910-A (NZ)
Title: Power generation system, apparatus and method
Inventor: NEAME MACDONALD
IPC: F03G1/02
Filed: 2007-08-30
Abstract: A power generation system for converting kinetic energy from a moving source into a useable form is disclosed. The power generation system includes: a) an input drive means adapted to be contactable with and receive kinetic energy from the moving source as the moving source passes over the input drive means; b) a transmission means adapted to be connected to the input drive means such that as the drive means receives kinetic energy from the moving source, the input drive means acts on the transmission means to generate rotational energy, the transmission means is further adapted such that as the drive means receives kinetic energy imparted to it from the moving source, the input drive means is caused to move in first direction relative to the transmission means and the input drive means is caused to move in a second direction relative to the transmission means when no energy is imparted to the input drive means. The transmission means further includes (i) at least one lever/fulcrum means connected to the input drive means and connected to a winding means; (ii) at least one drive shaft upon which the winding means is adapted to be wound; (iii) at least one drive cog connected to one end of the drive shaft having a drive releasing means such that the drive shaft is able to rotate in a first rotational direction in order to rotate the drive cog and freewheel relative to the drive cog in a second rotational direction without rotating the drive cog; and (iv) at least one return biasing means adapted to cause the input drive means to move in the second direction. The transmission means is such that as the input drive means moves in the first direction, the lever/fulcrum means causes the winding means to unwind from the drive shaft and in so doing causes the drive shaft to rotate in the first rotational direction and thus rotates the drive cog and as the input drive means moves in the second direction by the action of the return biasing means, the lever/fulcrum means causes the drive shaft to rotate in the second rotational direction without imparting drive to the drive cog and to wind the winding means onto the drive shaft; The power generation system also includes c) a storage means adapted to be coupled to an output of the transmission means such that rotational energy produced by the transmission means is converted and stored by the storage means as potential energy; and d) an output drive means connected to the storage means and connected to a generation means wherein the output drive means is adapted and arranged to be driven when the storage means is selectively activated by a releasing means to release the potential energy stored therein such that the output drive means drives the generation means to provide a source of power when required.
Patent NZ-573996-A (NZ)
Title: 4-Thiocarbamoyl-phenyl esters of statin derivatives
Inventor: WALLACE JOHN L
IPC: C07C327/48
Filed: 2007-07-18
Abstract: Disclosed are statin derivatives of the general formula A-Y-X; wherein A is a statin; Y is a succinic acid moiety; and X is 4-thiocarbamoyl-phenyloxy group. Of particular importance are compounds where A is selected from atorvastatin, cilastatin, dermostatin, fluvastatin, lovastatin, mevastatin, pravastatin sodium, and simvastatin; such as succinic acid 2-{ 2-[8-(2,2-dimethyl-butyryloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydro-naphthalen-1-yI]-ethyl} -6-oxo-tetrahydro-pyran-4-yl ester 4-thiocarbamoyl-phenyl ester.
Patent NZ-574046-A (NZ)
Title: Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration
Inventor: HAGEMAN GREGORY S
IPC: A01N61/00
Filed: 2007-07-13
Abstract: Disclosed are screening methods for determining a human subject's propensity to develop a vascular disorder and/or age-related macular degeneration (AMD), therapeutic or prophylactic compounds for treating disease or inhibiting its development, and methods of treating patients to alleviate symptoms of the disease, prevent or delay its onset, or inhibit its progression. The inventions are based on the discovery that persons with a genome having a deletion of the CFHR-1 and/or CFHR-3 gene, which normally lie on human chromosome 1 between DNA encoding CFH and CFHR-4, are at reduced risk of developing AMD, and elevated risk of developing vascular disease such as aneurysm.
Patent NZ-574972-A (NZ)
Title: Thaumatin-like (TL) polypeptide from a Lolium species
Inventor: SPANGENBERG GERMAN
IPC: C12N15/82
Filed: 2002-05-01
Abstract: Disclosed is a substantially purified or isolated nucleic acid or nucleic acid fragment encoding a thaumatin-like (TL) polypeptide or complementary or antisense to a sequence encoding a TL polypeptide and including a nucleotide sequence selected from the group consisting of (a) sequences shown in Figures 10, 12, 13, 15 and 42 hereto (Sequence ID Nos: 29, 31 to 34, 35, 37 and 38, and 68, respectively); (b) complements of the sequences recited in (a); (c) sequences antisense to the sequences recited in (a) and (b); and (d) functionally active fragments and variants that have at least approximately 80% identity to the relevant part of the sequences recited in (a), (b) and (c) and have a size of at least 20 nucleotides. Further disclosed are polypeptides encoded by said nucleic acids, constructs comprising said nucleic acids, vectors, uses and methods thereof. (62) Divided Out of 560640
Patent NZ-575748-A (NZ)
Title: Single web grid with double-layered bulb
Inventor: LALONDE PAUL D
IPC: E04B9/18
Filed: 2007-08-29
Abstract: A grid tee (46) for a suspended ceiling, soffit, or like structure, the grid tee being of the inverted tee style and being roll-formed from a single strip of sheet metal of a selected width bounded by opposed longitudinal edges. The tee has a lower flange, an upper hollow reinforcing bulb (48), and a web (17) extending between the flange and the bulb. The lower flange has portions on each side of the web that are of generally equal width. At least one of the flange portions is of a double layer. The web is of a single layer. The bulb has a width and height, the width being generally centred over the web. At least a portion of the bulb is a double layer (49) that increases the load rating of the tee.
Patent NZ-577094-A (NZ)
Title: Skin-piercing device for treatment of acne with skin piercing device projecting from housing 100 to 500 micormeters
Inventor: WU JEFFREY M
IPC: A61B5/15
Filed: 2007-11-21
Abstract: The disclosure features a skin-piercing device having a piercing element and the use thereof of treating acne. The device has a skin piercing portion which projects 100 to 500 micrometers from the housing. Further constructional details are disclosed.
Patent NZ-583446-A (NZ)
Title: Methods for the production of ansamitocins
Inventor: WIDDISON WAYNE C
IPC: C07D491/02
Filed: 2005-12-12
Abstract: Provided is a process for preparing purified ansamitocins comprising the steps of: 1) culturing an ansamitocin-producing microorganism in a liquid culture medium; 2) extracting ansamitocins from the culture medium with a water immiscible solvent, using various centrifugation techniques; 3) concentrating the extracted ansamitocins; and 4) purifying the ansamitocins by anyone of a), b), c) or d): a) adsorption chromatography over silica gel or alumina, b) crystallization, c) adsorption chromatography over silica gel or alumina followed by crystallization, d) crystallization followed by adsorption chromatography over silica gel or alumina. The microorganism can be Actinosynnema pretiosum deposit ATCC 31565.
Patent NZ-590051-A (NZ)
Title: Syringe with single use disabling mechanism where plunger is locked when depressed and thumb press is removed through force
Inventor: CAIZZA RICHARD J
IPC: A61M5/178
Filed: 2008-10-31
Abstract: A syringe assembly (100) having a passive disabling system to prevent reuse are provided. According to the embodiment, the syringe assembly comprises a barrel (420), plunger rod (440) and stopper (460) wherein the plunger rod further comprises a flexible protrusion (444) that locks the plunger rod within the barrel. The embodiment further includes a frangible portion (443) on the plunger rod that breaks when reuse is attempted. The embodiment includes a plunger rod and stopper attachment (446) that prevents disassembly of the syringe assembly prior to use. The syringe assembly also includes visual indicators or markers indicating whether a syringe assembly is used or the plunger rod is locked within the barrel.
Patent NZ-590067-A (NZ)
Title: Bi-and polycyclic substituted isoquinoline and isoquinolinone derivatives as rho kinase inhibitors
Inventor: PLETTENBURG OLIVER
IPC: A61K31/472
Filed: 2009-06-18
Abstract: Disclosed is a isoquinoline compound of formula (I), wherein R6 is either an adamantine system or a spirocyclic ring system, and all other substituents are as described within the specification. Examples of compounds of formula (I) include: 6-(4-Amino-adamantan-1-yloxy)-7-chloro-2H-isoquinolin-1-one; and 6-{ [(7-Endo,9-anti)-7-amino-3-oxabicyclo[3.3.1]non-9-yl]oxy} -7-chloroisoquinolin-1(2H)-one. Further disclosed is a compound of formula (I) in the preparation of a medicament for the treatment and/or prevention of hypertension, pulmonary hypertension, fibroid liver, liver failure, nephropathy, renal failure, chronic obstructive pulmonary disease (COPD), cerebral vasospasm, pain, spinal cord injury, erectile dysfunction, blood vessel restenosis, or cancer development and progression.
Patent NZ-591532-A (NZ)
Title: Solar energy conversion system having louvers with solar cells and fluid conduit on rear surface to recieve concentrated light from the concave reflective surface of a neighboring louver
Inventor: FRAZIER SCOTT
IPC: F24S23/79
Filed: 2009-08-06
Abstract: 591532 A solar energy conversion system is disclosed. The system includes louvers or slats (1020) with a first bottom surface (82) configured to receive solar cells and a fluid conduit in thermal contact with the surface. The fluid conduit comprises fluid entry and exit ends that also serve as pivots for the louver to revolve around its long axis. A second top surface of the louver comprises a concave reflective curvature to focus light (93) onto solar cells of a second neighbouring louver when installed.
Patent NZ-594122-A (NZ)
Title: 2-Phenyl-N-(2-(6-(pyrrolidin-1-ylmethyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)thiazole-4-carboxamide derivatives
Inventor: OALMANN CHRISTOPHER
IPC: A61K31/429
Filed: 2009-12-18
Abstract: 594122 Disclosed are 2-phenyl-N-(2-(6-(pyrrolidin-1-ylmethyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)thiazole-4-carboxamide derivatives as represented by the general formula (III), or a pharmaceutically acceptable salt thereof, wherein: R3 is selected from hydrogen, methoxypropyl, methoxyprop-1-ynyl, 3-(4-(2-methoxyethyl)piperazin-1-yl)propyl, (4-(2-methoxyethyl)piperazin-1-yl)methyl, pyrrolidin-1-ylmethyl, 3-(pyrrolidin-1-yl)propyl, (4-isopropylpiperazin-1-yl)methyl, morpholinomethyl or 3-morpholinopropyl. Representative compounds include 5-(3-methoxypropyl)-2-phenyl-N-(2-(6-(pyrrolidin-1-ylmethyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)thiazole-4-carboxamide, 2-phenyl-N-(2-(6-(pyrro1idin-1-ylmethyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)thiazole-4-carboxamide and 5-(3-methoxyprop-1-yn-1-yl)-2-phenyl-N-(2-(6-(pyrrolidin-1-ylmethyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)thiazole-4-carboxamide. Further disclosed is a pharmaceutical composition comprising a compound as defined above and a pharmaceutically acceptable carrier, for treating a subject suffering from or susceptible to insulin resistance, a metabolic syndrome, diabetes, or complications thereof, or for increasing insulin sensitivity in a subject.
Patent NZ-594261-A (NZ)
Title: Method for treating water by ballasted flocculation and settlement, including pre-contacting the water with an adsorbent
Inventor: SAUVIGNET PHILIPPE
IPC: C02F1/28
Filed: 2010-01-18
Abstract: 594261 Disclosed is a method for treating raw water laden with impurities in a treatment facility including at least one step of placing water in contact with a powdered adsorbent agent in an agitated pre-contact area (2), a step of ballasted flocculation, a step of settling, extracting a mixture of sludge, ballast and the powdered adsorbent agent from the bottom of the settlement area (5), and inserting the mixture in a hydrocyclone (11), transporting the overflow consisting of a mixture of sludge and powdered adsorbent reagent from said hydrocyclone (11) to a transition area (14). The method also includes a step of recycling the mixture of sludge and powdered adsorbent agent from the transition area (14) in the pre-contact area (2), continuously measuring at least one datum showing the concentration of powdered adsorbent agent in the pre-contact area (2), and a step of injecting a suspension of new powdered adsorbent agent in an aqueous medium upstream when the concentration of powdered adsorbent agent in the pre-contact area (2) is below a predetermined threshold value, as well as a step of acidifying said suspension of adsorbent agent.
Patent NZ-596905-A (NZ)
Title: Adaptor for a retractable syringe which removably mounts to the barrel of a syringe, wherein a sealing member in the adaptor is penetrable by a needle of the syringe
Inventor: THORLEY CRAIG STEPHEN
IPC: A61M5/31
Filed: 2010-06-16
Abstract: A syringe adapter mountable to a retractable syringe having a retractable needle. The adapter comprises a sealing member and an adapter body that comprises two or more body members that co-operate to retain the sealing member in the adapter. One or the other body members is removably mountable to a barrel of the syringe and one or the other body members comprises a mounting member. A filter member is removably mounted to, or formed integrally with, the mounting member to filters fluid when filling the syringe to thereby remove particular material, impurities or the like.
Patent NZ-597859-A (NZ)
Title: Ion plasma electron emitters for a melting furnace
Inventor: FORBES JONES ROBIN M
IPC: C22B9/16
Filed: 2010-08-10
Abstract: 597859 Disclosed is a furnace for melting an electrically conductive metallic material using two wire discharge ion plasma electron emitters. The apparatus comprises a vacuum chamber; a hearth disposed in the vacuum chamber; at least one ion plasma electron emitter disposed in or adjacent the vacuum chamber, the at least one ion plasma electron emitter being configured to produce a first field of electrons having a first area of coverage and sufficient energy to heat the electrically conductive metallic material to its melting temperature. The electrically conductive metallic material is at least one material selected from titanium, a titanium alloy, tungsten, niobium, tantalum, platinum, palladium, zirconium, iridium, nickel, a nickel base alloy, iron, an iron base alloy, cobalt, and a cobalt base alloy. The at least one ion plasma electron emitter is positioned to direct the first field of electrons into the vacuum chamber. At least one of a mold and an atomizing apparatus is positioned to receive the electrically conductive metallic material from the hearth; and an auxiliary ion plasma electron emitter disposed in or adjacent the vacuum chamber, the auxiliary ion plasma electron emitter being configured to produce a second field of electrons having a second area of coverage and sufficient energy to at least one of heat at least a portion of the electrically conductive metallic material to at least its melting temperature, melt solid condensate within the electrically conductive metallic material, and provide heat to regions of a forming ingot. The auxiliary ion plasma electron emitter is configured to focus the second field of electrons such that the second area of coverage is smaller than the first area of coverage. A steering device is configured for steering the second field of electrons emitted by the auxiliary ion plasma electron emitter to direct the focused second field of electrons toward at least one of the at least a portion of the electrically conductive metallic material, the solid condensate, and the forming ingot. The steering device is configured to selectively steer the second field of electrons produced by the auxiliary ion plasma electron emitter within at least a region of the first area of coverage.
Patent NZ-604946-A (NZ)
Title: Strapping system and connector therefor
Inventor: ROBERTSON ANGUS ANSTRUTHER
IPC: F16G11/14
Filed: 2012-12-19
Abstract: 604946 A strapping system for holding an item to be held in place is disclosed. The strapping system comprising: at least one webbing strap (200) and at least one connector arrangement (100). The connector arrangement defining at least one receiving slot into which a webbing strap is receivable, the receiving slot defining at least one shoulder formation configured for locating a closing formation.
Patent NZ-610136-A (NZ)
Title: Composition and method for treating skin conditions
Inventor: JACKSON MARK J
IPC: A61P17/00
Filed: 2011-11-03
Abstract: Disclosed is a composition comprising an imidazoquinoline compound and a retinoid agent for the treatment of a condition affecting the skin and/or mucosal surfaces of a subject (such as wart, molluscum contagiosum, keloid and skin cancer). A preferred combination is imiquimod and tazarotene.
Patent NZ-615219-A (NZ)
Title: Indolecarboxamides and benzimidazolecarboxamides as insecticides and acaricides
Inventor: MALSAM OLGA
IPC: A01N43/38
Filed: 2012-03-05
Abstract: Disclosed are indolecarboxamide and benzimidazole carboxamide compounds of the general formula (I), where the substituents are as defined herein, examples being; 5-(acetamidomethyl)-6-chloro-1-ethyl-N-(2,2,2-trifluoro-1-[3-(trifluoromethyl)phenyl]ethyl} -1H-indole-2-carboxamide and 6-chloro-N-1-dicyclopropyl-N-{ 2,2,2-trifluoro-1-[3-(trifluoromethyl)phenyl]ethyl} -1H-benzimidazole-2,5-dicarboxamide. Also disclosed are processes for the preparation thereof and the use of these compounds as insecticides and acaricides.
Patent NZ-615636-A (NZ)
Title: Mixer drum driving device
Inventor: TAKAHASHI YOSHIMITSU
IPC: B60P3/16
Filed: 2012-03-15
Abstract: 615636 Disclosed is a mixer drum driving apparatus (S). The present mixer drum driving apparatus (S) utilises a motor (3) mounted on the rear of a frame (C) in place of a conventional driving apparatus which uses a vehicle engine. The mixer drum driving apparatus (S) comprises a mixer drum (M) and a drive source (D). The mixer drum (M) is carried on a frame (C) of a mixer truck in a frontward tilted condition to be free to rotate. The drive source (D) is configured to drive the mixer drum (M) to rotate. The drive source (D) comprises a motor (3) which is disposed in a space between a rear portion of the mixer drum (M) and a rear portion of the frame (C) in order to drive the mixer drum (M) to rotate.
Patent NZ-615738-A (NZ)
Title: Methods for predicting and improving the survival of gastric cancer patients
Inventor: SINGH SHARAT
IPC: G01N33/574
Filed: 2012-04-04
Abstract: Disclosed is a method for predicting the survival of a subject having stage I or II gastric cancer after tumor surgery, the method comprising: (a) determining the presence of activation or the level of activation of at least two analytes comprising cMET and HER1 in a cancer cell obtained from the subject, wherein cMET and HER1 are coactivated in the cancer cell; and (b) predicting the survival of the subject based upon the presence of activation or the level of activation of the at least two analytes determined in step (a), wherein the subject is predicted to have worse survival compared to stage I or II gastric cancer subjects with cMET activation in the absence of HER1 activation. Also disclosed is a of a cMET inhibitor and a HER1 inhibitor for the manufacture of a medicament for treating a subject having stage I or II gastric cancer, wherein cMET and HER1 are coactivated in the stage I or II gastric cancer, and wherein the subject has worse survival and/or poorer prognosis compared to stage I or II gastric cancer subjects with cMet activation in the absence of HER1 activation.
Patent NZ-617145-A (NZ)
Title: Apparatus and method for improved presentation of objects in a distributed interactive simulation
Inventor: ALDRIDGE DAVID SCOTT
IPC: G09F19/00
Filed: 2012-05-03
Abstract: Systems and methods for substantially contemporaneously presenting a distributed simulation at multiple computing devices. A first computing device controls an object in the simulation. A second computing device generates a visual representation of the object associated with a visual status. The second computing device generates a predicted status and receives an update including new status from the first computing device. A portion of the predicted status is set equal to a portion of the new status, and a discrepancy between the predicted and visual statuses is determined. When the discrepancy is greater than a first threshold, at least one velocity of the predicted status may be modified. When the discrepancy is greater than a second threshold, the visual status is modified based at least in part on the predicted status. A new visual representation of the object is rendered based at least in part on the visual status, and displayed. These methods and systems allow for smoother motion of objects in distributed simulations, for example military simulations or video games.
Patent NZ-626662-A (NZ)
Title: 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives
Inventor: TRABANCO-SUÁREZ ANDRÉS AVELINO
IPC: C07D413/12
Filed: 2012-12-04
Abstract: The disclosure relates to 6-difluoromethyl-5,6-dihydro-2H-[1,4]oxazin-3-amine derivatives of formula (I). These work as inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2. The disclosure also relates to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer’s disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, cerebral amyloid angiopathy, multi-infarct dementia, Down’s syndrome, dementia associated with stroke, dementia associated with Parkinson’s disease and dementia associated with beta-amyloid.
Patent NZ-627654-A (NZ)
Title: Wind turbine rotor
Inventor: ROHDEN ROLF
IPC: F03D7/02
Filed: 2013-01-11
Abstract: A wind turbine rotor is provided which comprises a hub (2) and at least one blade (20) supported by said hub (2). The blade (20) comprises a first blade section (3) and a second blade section (4). The first blade section (3) is mounted to said hub (2) stationary with respect to said hub (2) and said second blade section (4) is supported by said first blade section (3) rotatably adjustable about a longitudinal axis of said blade (20). The second blade section (4) is supported by said first blade section (3) by at least two bearings (7a (not shown), 7b) which are spaced with respect to said longitudinal axis of said blade (20).